(Q46542397)

23 December 2017

title

A critical function for type I interferons in cancer immunoediting (English)

1 reference

23 December 2017

Erratum: Corrigendum: A critical function for type I interferons in cancer immunoediting

corrigendum / erratum

1 reference

12 July 2019

http://api.crossref.org/works?select=update-to&filter=doi:10.1038/NI0805-852B

author

James Michael White

10

1 reference

23 December 2017

author name string

Gavin P Dunn

1

1 reference

23 December 2017

Allen T Bruce

2

1 reference

23 December 2017

Kathleen C F Sheehan

3

1 reference

23 December 2017

Vijay Shankaran

4

1 reference

23 December 2017

Ravindra Uppaluri

5

1 reference

23 December 2017

Jack D Bui

6

1 reference

23 December 2017

Mark S Diamond

7

1 reference

23 December 2017

Catherine M Koebel

8

1 reference

23 December 2017

Cora Arthur

9

1 reference

23 December 2017

Robert D Schreiber

11

1 reference

23 December 2017

language of work or name

English

0 references

publication date

12 June 2005

1 reference

23 December 2017

published in

Nature Immunology

1 reference

23 December 2017

volume

6

1 reference

23 December 2017

page(s)

722-729

1 reference

23 December 2017

issue

7

1 reference

23 December 2017

IFNgamma and lymphocytes prevent primary tumour development and shape tumour immunogenicity

cites work

1 reference

Cancer immunoediting: from immunosurveillance to tumor escape

21 January 2018

1 reference

The three Es of cancer immunoediting

21 January 2018

1 reference

The immunobiology of cancer immunosurveillance and immunoediting

21 January 2018

1 reference

Enhanced in vivo growth and resistance to rejection of tumor cells expressing dominant negative IFN gamma receptors.

21 January 2018

1 reference

Demonstration of an interferon gamma-dependent tumor surveillance system in immunocompetent mice

21 January 2018

1 reference

The roles of IFN gamma in protection against tumor development and cancer immunoediting

21 January 2018

1 reference

CD4(+) T cells eliminate MHC class II-negative cancer cells in vivo by indirect effects of IFN-gamma

21 January 2018

1 reference

Injection of mice with antibody to interferon enhances the growth of transplantable murine tumors

21 January 2018

1 reference

Interferon and cell division. IX. Interferon-resistant L1210 cells: characteristics and origin.

21 January 2018

1 reference

Antibody to mouse interferon alpha/beta abrogates resistance to the multiplication of Friend erythroleukemia cells in the livers of allogeneic mice

21 January 2018

1 reference

Interferon-alpha in tumor immunity and immunotherapy

21 January 2018

1 reference

Inhibition of methylcholanthrene-induced carcinogenesis by an interferon gamma receptor-dependent foreign body reaction

21 January 2018

1 reference

CD4+ T cell--mediated tumor rejection involves inhibition of angiogenesis that is dependent on IFN gamma receptor expression by nonhematopoietic cells.

21 January 2018

1 reference

Links between innate and adaptive immunity via type I interferon

21 January 2018

1 reference

Natural adjuvants: endogenous activators of dendritic cells

21 January 2018

1 reference

Cross-priming of CD8+ T cells stimulated by virus-induced type I interferon

21 January 2018

1 reference

Type i interferons potently enhance humoral immunity and can promote isotype switching by stimulating dendritic cells in vivo.

21 January 2018

1 reference

Natural killer cells and cancer

21 January 2018

1 reference

Type I interferons keep activated T cells alive

21 January 2018

1 reference

Potent and selective stimulation of memory-phenotype CD8+ T cells in vivo by IL-15.

21 January 2018

1 reference

Integration of interferon-alpha/beta signalling to p53 responses in tumour suppression and antiviral defence.

21 January 2018

1 reference

p53, the cellular gatekeeper for growth and division

21 January 2018

1 reference

Type I interferon as a link between innate and adaptive immunity through dendritic cell stimulation

21 January 2018

1 reference

Interferon-producing cells: on the front line in immune responses against pathogens

21 January 2018

1 reference

Plasmacytoid dendritic cells in immunity

21 January 2018

1 reference

A weak signal for strong responses: interferon-alpha/beta revisited

21 January 2018

1 reference

Deficiencies of GM-CSF and Interferon γ Link Inflammation and Cancer

21 January 2018

1 reference

The antitumor effects of IFN-alpha are abrogated in a STAT1-deficient mouse

21 January 2018

1 reference

Antitumor effects of interferon in mice injected with interferon-sensitive and interferon-resistant Friend leukemia cells. I.

21 January 2018

1 reference

Hydrodynamics-based transfection in animals by systemic administration of plasmid DNA.

21 January 2018

1 reference

High levels of foreign gene expression in hepatocytes after tail vein injections of naked plasmid DNA.

21 January 2018

1 reference

Monoclonal antibodies specific for murine p55 and p75 tumor necrosis factor receptors: identification of a novel in vivo role for p75

21 January 2018

1 reference

BIOLOGY OF HEMATOPOIETIC STEM CELLS AND PROGENITORS: Implications for Clinical Application

21 January 2018

1 reference

Type I interferons produced by dendritic cells promote their phenotypic and functional activation

21 January 2018

1 reference

inferred from DOI database lookup

7 January 2021

based on heuristic

Antiviral response by natural killer cells through TRAIL gene induction by IFN-alpha/beta

1 reference

inferred from DOI database lookup

7 January 2021

based on heuristic

T-bet is a STAT1-induced regulator of IL-12R expression in naïve CD4+ T cells

1 reference

inferred from DOI database lookup

7 January 2021

based on heuristic

Identifiers

DOI

10.1038/NI1213

1 reference

23 December 2017

PubMed ID

15951814

1 reference

23 December 2017